164 related articles for article (PubMed ID: 12568213)
21. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
22. Do we need yet another blocker of the renin-angiotensin system?
Messerli FH; Re RN
J Am Coll Cardiol; 2007 Mar; 49(11):1164-5. PubMed ID: 17367659
[No Abstract] [Full Text] [Related]
23. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
24. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.
Futrakul N; Butthep P
Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141
[No Abstract] [Full Text] [Related]
25. ACE inhibition and renovascular disease.
Carr S
Diabet Med; 2001 Jan; 18 Suppl 1():4-6. PubMed ID: 11289190
[No Abstract] [Full Text] [Related]
26. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
[No Abstract] [Full Text] [Related]
27. [Combined blockade of renin-angiotensine system].
Robles NR
Nefrologia; 2003; 23(6):497-503. PubMed ID: 15002784
[No Abstract] [Full Text] [Related]
28. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
29. [ACE-I for patients with hypertension].
Hatta T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():318-21. PubMed ID: 16981561
[No Abstract] [Full Text] [Related]
30. [Dual blockade of the renin-angiotensin system].
Andersen NH; Mogensen CE
Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
[No Abstract] [Full Text] [Related]
31. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
32. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
[TBL] [Abstract][Full Text] [Related]
33. [ACE-inhibitors in renal protection].
Barna I
Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
[TBL] [Abstract][Full Text] [Related]
34. The case for dual Renin-Angiotensin system inhibition.
Hirsch S
Arch Intern Med; 2009 Nov; 169(20):1931; author reply 1931. PubMed ID: 19901153
[No Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin system in diabetic nephropathy.
Chen S; Wolf G; Ziyadeh FN
Contrib Nephrol; 2001; (135):212-21. PubMed ID: 11705286
[No Abstract] [Full Text] [Related]
37. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
Gradman AH; Papademetriou V
Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
[TBL] [Abstract][Full Text] [Related]
38. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
Smahelová A
Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
[No Abstract] [Full Text] [Related]
39. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
40. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Weir MR
Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
